TY  - CONF

T1  - Dupilumab Safety and Efficacy Up To 3 Years In Children Aged 6 Months to 11 Years With Atopic Dermatitis

JO  - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PY  - 2025/09/01

AU  - Paller AS

AU  - Simpson EL

AU  - Siegfried EC

AU  - Cork MJ

AU  - Arkwright PD

AU  - Eichenfield L

AU  - Dubost-Brama A

AU  - You X

AU  - Bansal A

AU  - Prescilla R

AU  - Nguyen TV

ED  - 

VL  - 93

IS  - 3

SP  - AB178

EP  - AB178

Y2  - 2025/10/26

ER  -